Reason for request
Inclusion on the list of medicines refundable by National Health Insurance and approved for hospital use.
Clinical Benefit
| Low |
The actual benefit of BRONCHITOL is low. |
Clinical Added Value
| no clinical added value |
BRONCHITOL does not offer any improvement in actual benefit (IAB V) in the management of adult patients aged 18 and over with cystic fibrosis. |
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
q7mV61DzGFPYS8L3
Listen
